Kati Copley-Merriman

RTI uses cookies to offer you the best experience online. By clicking “accept” on this website, you opt in and you agree to the use of cookies. If you would like to know more about how RTI uses cookies and how to manage them please view our Privacy Policy here. You can “opt out” or change your mind by visiting: http://optout.aboutads.info/. Click “accept” to agree.

Search Publications

Filter by Year

Filter by Publication Type

Search Results

Biologics In Ulcerative Colitis (Uc): Treatment Guidelines and Health Technology Assessments (Hta)

Benefits of patient-reported outcomes in dermatology drug development

Symptoms and toxicity of rituximab maintenance relative to observation following immunochemotherapy in patients with follicular lymphoma

Utility estimates for patients with Type 2 diabetes mellitus after experiencing a myocardial infarction or stroke: A systematic review

Factors affecting the health-related quality of life of patients with cervical dystonia and impact of treatment with abobotulinumtoxinA (Dysport): Results from a randomised, double-blind, placebo-controlled study

Incremental costs associated with myocardial infarction and stroke in patients with type 2 diabetes mellitus: An overview for economic modeling

Patient-reported outcome labeling claims and measurement approach for metastatic castration-resistant prostate cancer treatments in the United States and European Union

Payer Needs in Emerging Markets: How Should These Needs be Included in Dermatology Drug Development Plans?

Systematic Literature Reviews at the Heart of Health Technology Assessment: A Comparison Across Markets

Measuring patient-reported outcomes in advanced gastric cancer

Health-related quality of life and symptoms in patients with myelofibrosis treated with ruxolitinib versus best available therapy

Evidence-based medicine, appropriate-use criteria, and sports medicine: How best to develop meaningful treatment guidelines

Do different clinical evidence bases lead to discordant health-technology assessment decisions? An in-depth case series across three jurisdictions

Systematic literature review of utilities relating to patients with type-2 diabetes mellitus experiencing a stroke ro myocardial infarction

Surgical Innovation: do We Need A More Balanced Framework for Evidence?

Systematic Literature Review of Costs Related to Patients with Type-2 Diabetes Mellitus Experiencing A Stroke Or Myocardial Infarction

Systematic Literature Review of the Temporal Relationship Between Nsaid Use and Gastrointestinal, Cardiovascular, Or Renal Events

Health-related quality of life and symptoms in patients with myelofibrosis treated with ruxolitinib versus best available therapy.

High burden and unmet patient needs in chronic kidney disease

A review of patient-reported outcome labels in the United States: 2006 to 2010